Skip to content

Dr Castelain

Active
Private limited company·Activiteiten van huisartspraktijken· 4 yrs active
Arthur Andréstraat 53 ·1150 Sint-Pieters-Woluwe, Belgium
BE 0785.530.843
Watch Print / PDF
Age4 yrs

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of Dr Castelain is 0.4% (very low). The 2024 annual accounts show equity of €22k and a net result of €10k. Equity is growing by ~59.5% per year across the filed fiscal years. Its solvency ranks better than 50% of 6549 sector peers (fiscal year 2024). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 3 annual accounts.

Signals

2 signals · with evidence
Consistently profitable
Positive net result in the two most recent financial years (2023 and 2024).
View the result trend
Growing equity
Equity grew over 2022-2024. Profits are largely retained rather than distributed.
View the equity trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Trust signals

3 signals
More than 3 years active
Founded in 2022, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).

Administrative Flags

0 events
No administrative flags

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.4% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector Young company +Higher-failure-rate region +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€10k+123.0%
Working capital€21k+99.0%

Annual accounts & ratios

Source: NBB · 2024
Annual accounts filed on 31-08-2025 with the NBB · fiscal year 2024 · micro
€0€5k€10k€15kOperating result 2022: €9k€9kNet result 2022: €6k€6kOperating result 2023: €9k€9kNet result 2023: €5k€5kOperating result 2024: €15k€15kNet result 2024: €10k€10k202220232024
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing Equity: growth of ~59.5%/year over 3 fiscal years, indicative, assuming unchanged policy.
€0€10k€20k€30k€40k€50k2025: €30k (€28k - €32k)2026: €37k (€35k - €39k)2027: €44k (€43k - €46k)2022: €8k2023: €12k2024: €22k202220232024202520262027
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2024 · NACE 86, Human health · compared within the same schema type (micro schema)
Metric This company Sector median Position in the sector
Solvency 66.7% 66.7%
better than 50% of 6549 sector peers
Net result €10k €46k
better than 19% of 6543 sector peers
Equity €22k €79k
better than 20% of 6549 sector peers
Gross operating margin €16k €78k
better than 12% of 6551 sector peers
Total assets €34k €154k
better than 9% of 6552 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Sector position over time
Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).
Solvency P50
2022: P27 · n=36472023: P33 · n=53092024: P50 · n=65492022 2024
Improving position over 2022-2024 · n=3647-6549
Net result P19
2022: P17 · n=36452023: P15 · n=53082024: P19 · n=65432022 2024
Stable position over 2022-2024 · n=3645-6543
Equity P20
2022: P13 · n=36472023: P16 · n=53112024: P20 · n=65492022 2024
Stable position over 2022-2024 · n=3647-6549
Gross operating margin P12
2022: P12 · n=36432023: P12 · n=53052024: P12 · n=65512022 2024
Stable position over 2022-2024 · n=3643-6551
Describes the position versus peers, not a forecast.
EBITDA
€16k
+56.8% -78% vs sector
Net profit
€10k
+123.0% -79% vs sector
Cash flow
€11k
+95.8% -81% vs sector
Total assets
€34k
+25.8% -90% vs sector
Equity
€22k
+82.1% -92% vs sector
Working capital
€21k
+99.0% -92% vs sector
Income taxes
€5k
+57.5% -54% vs sector
Dividends
€0
-100.0% -100% vs sector
Debt
€11k
-22.4% -66% vs sector
Debt ≤ 1y
€10k
-23.6% -68% vs sector
Current ratio
3.02
+70.2% -52% vs sector
Quick ratio
3.02
+70.2% -52% vs sector
Solvency
66.7%
+44.8% -26% vs sector
Debt / equity
0.50
-57.4% far above sector median
ROE
45.1%
+22.4% +198% vs sector
ROA
30.1%
+77.3% +111% vs sector
Interest coverage
14.43
+219.7% -78% vs sector
Figures by fiscal year
Fiscal year2024
Revenue-
EBITDA€16k
Net profit€10k
Cash flow€11k
Staff costs-
Income taxes€5k
Dividends-
Total assets€34k
Equity€22k
Debt€11k
of which ≤ 1y€10k
of which > 1y-
Working capital€21k
Employees (FTE)-
Ratios (computed)
2024
Current ratio3.02
Quick ratio3.02
Working capital ratio62.8%
Solvency66.7%
Debt / equity0.50
Long-term debt ratio-
Interest coverage14.43
Gross margin-
Net margin-
ROA30.1%
ROE45.1%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2024
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2024
Balance sheet, Assets
TOTAL ASSETS 20/58€34k
Fixed assets 21/28€1k
Formation expenses 20€615
Tangible fixed assets 22/27€1k
Current assets 29/58€32k
Amounts receivable within one year 40/41€11k
Cash & bank 54/58€2k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€34k
Equity 10/15€22k
Contributions / capital 10/11€3k
Accumulated profits (losses) 14€20k
Amounts payable 17/49€11k
Amounts payable within one year 42/48€10k
Trade debts payable within one year 44€1k
Income statement
Gross operating margin 9900€16k
Operating result 9901€15k
Financial income 75€874
Financial charges 65€1k
Result before taxes 9903€15k
Income taxes 67/77€5k
Net result for the period 9904€10k
Result to be appropriated 9905€10k
You're seeing the latest fiscal year only. Unlock 2 prior years (figures + ratios) with a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2024 · computed
100 / 100 Excellent
050100

Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.

See plans →
Computed by Checked from NBB filings and Belgian State Gazette signals. Indicative, not credit advice.

Structure & network

Locations & real estate

Establishment units

1 location
Dr Castelain
Arthur Andréstraat 53, 1150 Sint-Pieters-WoluweActiviteiten van huisartspraktijken
since 20222.331.473.984
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area268 m²
Buildings1
Building footprint64 m²
Volume (LiDAR)428 m³
Tallest building10.8 m · ±2 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21683D0010/00S000 Brussels 268 m² 1 · 63 m² 10.8 m · 2 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Analysis

Snowflake analysis

financial profile on 5 axes
Health100Profitability100Solvency100Growth78Stability94
94 / 100

Exceptional profile, strong across almost every axis.

Health 100
Profitability 100
Solvency 100
Growth 78
Stability 94

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
AI-generated from Checked data; indicative, not legal or investment advice.

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Same sector, nearest first

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Huisartspraktijken86210Activiteiten van huisartspraktijken86210
Primary activity highlighted.
Names & trade names
Legal nameFR Dr Castelain
Registered office
Arthur Andréstraat 53 bus 101
1150 Sint-Pieters-Woluwe, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.